Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Molecular Diagnostics Testing and Next Generation Sequencing
gracevideo
Kurt Davies, PhD, and Nirali Patel MD, join GRACE to discuss Molecular Diagnostic Testing and Next Generation Sequencing, in audio-only format.
Image
The Global Resource for Advancing Cancer Education (GRACE)
presents
Molecular Diagnostic Testing and Next Generation Sequencing Webinar Series
Kurt Davies, PhD, Instructor with the University of Colorado Health Sciences Center – Department of Pharmacology, and Nirali Patel MD, Assistant Professor, Department of Pathology and Laboratory Medicine, UNC School of Medicine join GRACE to discuss Molecular Diagnostic Testing and Next Generation Sequencing. This extremely informative (audio only) webinar series discusses cancer cell biology, targeted therapies, genetic testing, the importance of retesting in cases of resistance, and next generation sequencing.
Cancer Cell Biology 101, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
How Targeted Therapies Treat Cancer, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
How it Works: Genetic Testing in Lung Cancer, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
Resistance to Targeted Therapies, and the Importance of Retesting, Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus
What is Next Generation Sequencing (NGS)? Presented by Nirali Patel MD, Assistant Professor, Department of Pathology and Laboratory Medicine, UNC School of Medicine
GRACE would like to thank the following sponsors for their support of this program
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Image
Video
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.
¡Los vídeos están disponibles BAJO DEMANDA!
Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.
Image
Article
Da click aquí para más información y para registrarte ahora
Online Community
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...